secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001493152-26-004237
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic raises $358.5K via secured convertible note with Mast Hill Fund
-------------------------------------------------------------------------

- Issued $398,333.33 convertible promissory note (10% OID, 10% interest, 1-year maturity) to Mast Hill Fund for net proceeds of ~$350K after fees.
- Note convertible at $0.07/share; also issued 1,422,613 warrants at $0.15/share and 1,600,446 commitment shares.
- Note secured against company assets excluding certain JV assets (OT-101, CA4P, Oxi4503, AI technologies).
- Proceeds designated for general working capital; prepayment allowed with 3 trading days' notice.
- Shares issuable upon conversion/exercise not registered; registration rights agreement filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315226004237/0001493152-26-004237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315226004237/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer